Semi-Annual Consolidated Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7719076

Concept 2018-04-01 to
2018-09-30
2017-04-01 to
2017-09-30
Semi-annual consolidated statement of income
Statement of income
Net sales
142,435,000 JPY
182,683,000 JPY
Cost of sales
66,741,000 JPY
177,943,000 JPY
Gross profit (loss)
75,694,000 JPY
4,739,000 JPY
Ordinary profit (loss)
-822,396,000 JPY
-685,187,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
901,786,000 JPY
690,660,000 JPY
Extraordinary losses
192,671,000 JPY
JPY
Profit (loss) before income taxes
-1,015,067,000 JPY
-685,187,000 JPY
Operating profit (loss)
-826,092,000 JPY
-685,920,000 JPY
Income taxes - current
1,925,000 JPY
2,609,000 JPY
Non-operating income
Interest income
31,000 JPY
23,000 JPY
Non-operating income
7,666,000 JPY
733,000 JPY
Non-operating expenses
Non-operating expenses
3,971,000 JPY
JPY
Income taxes - deferred
350,000 JPY
810,000 JPY
Income taxes
2,275,000 JPY
3,420,000 JPY
Profit (loss)
-1,017,343,000 JPY
-688,607,000 JPY
Extraordinary losses
Impairment losses
192,671,000 JPY
JPY
Profit (loss) attributable to non-controlling interests
JPY
-1,274,000 JPY
Profit (loss) attributable to owners of parent
-1,017,343,000 JPY
-687,332,000 JPY
Comprehensive income
-1,017,343,000 JPY
-688,607,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-1,017,343,000 JPY
-687,332,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
-1,274,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.